Petros Pharmaceuticals to Present at the Access to Giving Virtual Investor Conference on July 14, 2021
Petros Pharmaceuticals (Nasdaq: PTPI) has announced that its President and Chief Commercial Officer, Fady Boctor, will present at the Access to Giving Virtual Investor Conference from July 13 to 15, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals (Nasdaq: PTPI) has announced that its President and Chief Commercial Officer, Fady Boctor, will present at the Access to Giving Virtual Investor Conference from July 13 to 15, 2021. Boctor's presentation is scheduled for July 14 at 3:30pm ET. Interested parties can register for the event through a provided link or request one-on-one meetings via email. The company aims to be a leader in men's health by developing innovative therapies for various conditions including erectile dysfunction and hormone health.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was -0.26%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, July 12, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 – 15, 2021.
Mr. Boctor will deliver his corporate presentation on July 14 at 3:30pm ET.
To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com.
Investors can register here.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-14-2021-301331250.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.